Advertisement
UK markets close in 4 hours 3 minutes
  • FTSE 100

    8,089.96
    +49.58 (+0.62%)
     
  • FTSE 250

    19,705.27
    -14.10 (-0.07%)
     
  • AIM

    754.83
    +0.14 (+0.02%)
     
  • GBP/EUR

    1.1662
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2514
    +0.0051 (+0.41%)
     
  • Bitcoin GBP

    50,991.64
    -2,073.65 (-3.91%)
     
  • CMC Crypto 200

    1,353.07
    -29.50 (-2.14%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD FUTURES

    2,341.70
    +3.30 (+0.14%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,949.65
    -139.05 (-0.77%)
     
  • CAC 40

    8,015.93
    -75.93 (-0.94%)
     

Tscan Therapeutics Inc (TCRX) CEO David P Southwell Bought $96,030 of Shares

- By insider

CEO of Tscan Therapeutics Inc (30-Year Financial, Insider Trades) David P Southwell (insider trades) bought 11,000 shares of TCRX on 09/08/2021 at an average price of $8.73 a share. The total cost of this purchase was $96,030.


For the complete insider trading history of TCRX, click here

.This article first appeared on GuruFocus.